UK markets closed
NIKKEI 225
27,362.75 -32.26 (-0.12%) HANG SENG
22,566.78 +522.13 (+2.37%) CRUDE OIL
81.10 +0.09 (+0.11%) GOLD FUTURES
1,929.70 -12.90 (-0.66%) DOW
33,949.41 +205.57 (+0.61%) BTC-GBP
18,576.59 -88.56 (-0.47%)
Esperion Therapeutics, Inc. (ESPR)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 6.69 |
| Open | 6.77 |
| Bid | 6.40 x 800 |
| Ask | 6.64 x 1800 |
| Day's range | 6.55 - 6.90 |
| 52-week range | 3.28 - 8.87 |
| Volume | |
| Avg. volume | 1,935,696 |
| Market cap | 496.09M |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
PTC Therapeutics (PTCT) Soars 5.8%: Is Further Upside Left in the Stock?
PTC Therapeutics (PTCT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- Zacks
Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?
Here is how CTI BioPharma (CTIC) and Esperion Therapeutics (ESPR) have performed compared to their sector so far this year.
- Zacks
Esperion (ESPR) Reports Positive Data From CLEAR Study
Esperion (ESPR) announces positive data from the CLEAR Outcomes study, which further strengthens the clinical evidence supporting the role of bempedoic acid for patients and will boost the growth potential of the drug.
© 2023 Yahoo. All rights reserved.
